Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Probation Termination topic
No spam. Unsubscribe anytime.
Board hears petition from pharmacist Farzad Pirouz seeking early end to probation
Summary
The disciplinary petition committee heard testimony from pharmacist Farzad J. Pirouz, who asked for early termination of a five‑year probation imposed after allegations of improper dispensing and failures of corresponding responsibility. Deputy AG Christina Jarvis urged denial, citing patient‑safety red flags and unreliable support letters.
Farzad J. Pirouz, a pharmacist whose license was placed on five‑year probation after an accusation alleging failures in corresponding responsibility and dispensing irregular prescriptions, asked the California State Board of Pharmacy disciplinary petition committee on Dec. 3 to end his probation early.
Deputy Attorney General Christina Jarvis summarized the case, saying the accusation (filed Sept. 26, 2022) documented objective red flags: ‘‘For schedule II controlled substances, the percentage of cash pays was nearly 64 percent,’’ she said, and she described multiple prescribers and patient groups linked by suspicious patterns. Jarvis told the committee that petitioner had outstanding investigation costs of approximately $14,658.25 as of Nov. 21, 2025, and moved the petition packet into evidence.
Petitioner Farzad (Jack) Perouse testified that he has completed remedial education, logged continuing education hours, performed volunteer work and worked under a supervising pharmacist at Westside Medical Pharmacy. He said he sought early termination in part to avoid private‑payer network (PBM) terminations that could force his employer to close and leave his family without support. ‘‘I’m a different pharmacist now,’’ Perouse said, describing changes in practice and supervision.
Board members pressed Perouse on past conduct. Member Claudio Mercado highlighted the opioid crisis and asked why Perouse had not exercised corresponding responsibility to confirm prescriber legitimacy; Perouse acknowledged negligence and said he had implemented documented checks, consultant oversight and quarterly reviews. Jarvis urged the committee at closing to deny the petition, saying Perouse ‘‘needs more time to consider rectifying his practice…and finish paying his cost recovery’’ and recommending denial.
The ALJ admitted exhibits and closed the record; the committee submitted the matter for deliberation in closed session. The committee did not make a public decision on Dec. 3.
Next steps: The board will deliberate in closed session and notify the parties of its decision at a later date.
